{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:06:22Z","timestamp":1791133582490,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T00:00:00Z","timestamp":1280275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:sec><jats:label\/><jats:p>S\u00e1nchez\u2010L\u00e1zaro IJ, Almenar L, Mart\u00ednez\u2010Dolz L, Buend\u00eda\u2010Fuentes F, Ag\u00fcero J, Navarro\u2010Manch\u00f3n J, Vicente J\u2010L, Salvador A. A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil and steroids in heart transplantation.\u2028Clin Transplant 2011: 25: 606\u2013613. \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Cyclosporine (CsA) and tacrolimus (Tac) in heart transplantation (HTx) have been compared but with certain drawbacks. We compared both drugs in a prospective analysis with medium\u2010term follow\u2010up.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Hundred and six patients were randomized to receive CsA or Tac (53 per group). Target levels of CsA were 200\u2013300\u2003ng\/mL in the first six months and 100\u2013200\u2003ng\/mL thereafter. Tac levels were 10\u201315 and 5\u201310\u2003ng\/mL, respectively. We also used daclizumab as induction and mycophenolate mofetil (MMF) and steroids as maintenance therapy.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Baseline characteristics were similar. Survival (CsA 88.7% vs. Tac 81.1%; p\u2003=\u20030.493) was similar. There was a tendency for longer time to first rejection with CsA (93\u2003\u00b1\u2003110 vs. 55\u2003\u00b1\u200381\u2003d; p\u2003=\u20030.122). There were more rejection\u2010free patients with Tac (39 vs. 28%; p\u2003=\u20030.233). CsA patients suffered more viral infections (0.41\u2003\u00b1\u20030.58 vs. 0.11\u2003\u00b1\u20030.31; p\u2003=\u20030.003). CsA patients developed hypertension often (64 vs. 43%; p\u2003=\u20030.032). Tac patients suffered more gastrointestinal complications (16 vs. 6%; p\u2003=\u20030.042). Renal function and the development of diabetes, dyslipidemia, or neurological complications was similar.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Tac patients showed a tendency for longer time to first rejection, and there were more rejection\u2010free patients with Tac and suffered fewer viral infections. Tac patients developed less hypertension and needed less drugs for its control. Renal function was similar in both groups.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1399-0012.2010.01309.x","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T10:21:37Z","timestamp":1280312497000},"page":"606-613","source":"Crossref","is-referenced-by-count":11,"title":["A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation"],"prefix":"10.1111","volume":"25","author":[{"given":"Ignacio J.","family":"S\u00e1nchez\u2010L\u00e1zaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez\u2010Dolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Buend\u00eda\u2010Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Navarro\u2010Manch\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9\u2010Luis","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinio","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,16]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1271","article-title":"The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town","volume":"41","author":"Barnard CN","year":"1967","journal-title":"S Afr Med J"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-5223(19)36981-8","article-title":"Eight year results of cyclosporine\u2010treated patients with cardiac transplants","volume":"99","author":"Grattan MT","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(01)00323-0"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2003.12.038"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91014-3"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(02)00815-X"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(96)70336-7"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(98)00060-6"},{"key":"e_1_2_7_10_2","first-page":"1001","article-title":"FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study","volume":"16","author":"Rinaldi M","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.08.014"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000129814.52456.25"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.08.059"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2004.11.006"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01300.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2005.11.452"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(01)01906-6"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200212150-00014"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01290.x"},{"key":"e_1_2_7_20_2","first-page":"432","article-title":"The glomerular filtration rate estimated by MDRD predictive equation in unselected end\u2010stage renal failure patients: differences from average of creatinine and urea clearances","volume":"22","author":"Caravaca F","year":"2002","journal-title":"Nefrolog\u00eda"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.08.113"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-470X(03)00022-3"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1157\/13127849"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2005.03.019"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.06.057"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.10.004"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2008.00875.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hco.0000203184.89158.16"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.09.161"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.05.036"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2010.01309.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2010.01309.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T13:25:11Z","timestamp":1697376311000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2010.01309.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1399-0012.2010.01309.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01309.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}